Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells

Toxicology and Applied Pharmacology

Volumn 283, Issue 2, 2015, Pages 75-82

  Chen, Li Jun ^a   Ye, Hong ^a,b   Zhang, Qian ^a   Li, Feng Zhi ^a   Song, Lin Jie ^a   Yang, Jie ^a   Mu, Qing ^a   Rao, Shan Shan ^a   Cai, Peng Cheng ^a   Xiang, Fei ^a,b   Zhang, Jian Chu ^a,b   Su, Yunchao ^c   Xin, Jian Bao ^a,b   Ma, Wan Li ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING HOSPITAL   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Bleomycin; Collagen; Epithelial mesenchymal transition (EMT); Fibrosis; Lung; Pleural mesothelial cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; CALRETININ; COLLAGEN TYPE 1; CYTOKERATIN 8; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN; ANTINEOPLASTIC ANTIBIOTIC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELL MIGRATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; MESOTHELIUM CELL; MET 5A CELL; MOUSE; NONHUMAN; PLEURAL FIBROSIS; PLEURAL MESOTHELIAL CELL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING ASSAY; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM; HUMAN; LUNG; PATHOLOGY; RESPIRATORY TRACT MUCOSA;

ANIMALIA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; HUMANS; LUNG; MALE; MICE; MICE, INBRED C57BL; RESPIRATORY MUCOSA;

EID: 84921850946     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.01.004     Document Type: Article

References (23)

1. Berg J.M., Romoser A.A., Figueroa D.E., Spencer West C., Sayes C.M. Comparative cytological responses of lung epithelial and pleural mesothelial cells following in vitro exposure to nanoscale SiO2. Toxicol. in Vitro 2013, 27:24-33.
2. Chapman H.A. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu. Rev. Physiol. 2011, 73:413-435.
3. Chung M.P., Monick M.M., Hamzeh N.Y., Butler N.S., Powers L.S., Hunninghake G.W. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am. J. Respir. Cell Mol. Biol. 2003, 29:375-380.
4. Decologne N., Wettstein G., Bonniaud P. A role for mesothelial cells in the genesis of idiopathic pulmonary fibrosis?. Bull. Acad. Natl Med. 2010, 194:383-389.
5. Eriksson J.E., Dechat T., Grin B., Helfand B., Mendez M., Pallari H.M., Goldman R.D. Introducing intermediate filaments: from discovery to disease. J. Clin. Invest. 2009, 119:1763-1771.
6. Hashimoto N., Jin H., Liu T., Chensue S.W., Phan S.H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 2004, 113:243-252.
7. Kachali C., Eltoum I., Horton D., Chhieng D.C. Use of mesothelin as a marker for mesothelial cells in cytologic specimens. Semin. Diagn. Pathol. 2006, 23:20-24.
8. Kage H., Borok Z. EMT and interstitial lung disease: a mysterious relationship. Curr. Opin. Pulm. Med. 2012, 18:517-523.
9. Kawai K., Akaza H. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer. Expert Opin. Drug Saf. 2003, 2:587-596.
10. Kim S.N., Lee J., Yang H.S., Cho J.W., Kwon S., Kim Y.B., Her J.D., Cho K.H., Song C.W., Lee K. Dose-response effects of bleomycin on inflammation and pulmonary fibrosis in mice. Toxicol. Res. 2010, 26:217-222.
11. Kim C., Kim D.G., Park S.H., Hwang Y.I., Jang S.H., Kim C.H., Jung K.S., Min K., Lee J.W., Jang Y.S. Epithelial to mesenchymal transition of mesothelial cells in tuberculous pleurisy. Yonsei Med. J. 2011, 52:51-58.
12. King T.E., Brown K.K., Raghu G., du Bois R.M., Lynch D.A., Martinez F., Valeyre D., Leconte I., Morganti A., Roux S., Behr J. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2011, 184:92-99.
13. Lee R., Reese C., Bonner M., Tourkina E., Hajdu Z., Riemer E.C., Silver R.M., Visconti R.P., Hoffman S. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 306:L736-L748.
14. Lim J., Thiery J.P. Epithelial-mesenchymal transitions: insights from development. Development 2012, 139:3471-3486.
15. Moore B.B., Hogaboam C.M. Murine models of pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L152-L160.
16. Mouratis M.A., Aidinis V. Modeling pulmonary fibrosis with bleomycin. Curr. Opin. Pulm. Med. 2011, 17:355-361.
17. Mubarak K.K., Montes-Worboys A., Regev D., Nasreen N., Mohammed K.A., Faruqi I., Hensel E., Baz M.A., Akindipe O.A., Fernandez-Bussy S., Nathan S.D., Antony V.B. Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis. Eur. Respir. J. 2012, 39:133-140.
18. Nasreen N., Mohammed K.A., Mubarak K.K., Baz M.A., Akindipe O.A., Fernandez-Bussy S., Antony V.B. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L115-L124.
19. Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., Colby T.V., Cordier J.F., Flaherty K.R., Lasky J.A., Lynch D.A., Ryu J.H., Swigris J.J., Wells A.U., Ancochea J., Bouros D., Carvalho C., Costabel U., Ebina M., Hansell D.M., Johkoh T., Kim D.S., King T.E., Kondoh Y., Myers J., Muller N.L., Nicholson A.G., Richeldi L., Selman M., Dudden R.F., Griss B.S., Protzko S.L., Schunemann H.J. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011, 183:788-824. Fibrosis, A.E.J.A.C.o.I.P.
20. Savani R.C., Zhou Z., Arguiri E., Wang S., Vu D., Howe C.C., DeLisser H.M. Bleomycin-induced pulmonary injury in mice deficient in SPARC. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L743-L750.
21. Willis B.C., Liebler J.M., Luby-Phelps K., Nicholson A.G., Crandall E.D., du Bois R.M., Borok Z. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 2005, 166:1321-1332.
22. Yi H., Ku N.O. Intermediate filaments of the lung. Histochem. Cell Biol. 2013, 140:65-69.
23. Zolak J.S., Jagirdar R., Surolia R., Karki S., Oliva O., Hock T., Guroji P., Ding Q., Liu R.M., Bolisetty S., Agarwal A., Thannickal V.J., Antony V.B. Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury. Am. J. Pathol. 2013, 182:1239-1247.